Shine-On BioMedical Co.,Ltd. Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	9.52	9.52	-	-
Cost of Revenue	2.86	2.86	-	-
Gross Profit	6.67	6.67	-	-
Selling, General & Admin	15.4	15.11	11.72	3.5
Research & Development	81.65	54.24	6.9	7.99
Operating Expenses	97.05	69.35	18.61	11.5
Operating Income	-90.38	-62.68	-18.61	-11.5
Interest Expense	-0.01	-0.01	-0.03	-0.02
Interest & Investment Income	16.64	20.07	8.19	0.28
Currency Exchange Gain (Loss)	4.34	7.69	-11.37	-
Other Non Operating Income (Expenses)	0.03	0.01	-	-
Pretax Income	-69.73	-34.94	-21.82	-11.24
Income Tax Expense	1.1	2.23	-2.27	-
Net Income	-70.83	-37.17	-19.54	-11.24
Net Income to Common	-70.83	-37.17	-19.54	-11.24
Shares Outstanding (Basic)	50	50	45	18
Shares Outstanding (Diluted)	50	50	45	18
Shares Change (YoY)	2.03%	9.67%	145.83%	-
EPS (Basic)	-1.42	-0.75	-0.43	-0.61
EPS (Diluted)	-1.42	-0.75	-0.43	-0.61
Free Cash Flow	-60.52	-26.95	-22.14	-10.71
Free Cash Flow Per Share	-1.22	-0.54	-0.49	-0.58
Gross Margin	70.00%	70.00%	-	-
Operating Margin	-949.01%	-658.16%	-	-
Profit Margin	-743.71%	-390.22%	-	-
Free Cash Flow Margin	-635.41%	-282.94%	-	-
EBITDA	-89.65	-61.97	-18.07	-11.22
D&A For EBITDA	0.74	0.71	0.55	0.28
EBIT	-90.38	-62.68	-18.61	-11.5

Source: S&P Capital IQ. Standard template. Financial Sources.